Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Treasury Shares (2018 - 2025)

Black Diamond Therapeutics (BDTX) has disclosed Treasury Shares for 2 consecutive years, with $30667.0 as the latest value for Q3 2021.

  • For the quarter ending Q3 2021, Treasury Shares fell 48.31% year-over-year to $30667.0, compared with a TTM value of $30667.0 through Sep 2021, down 48.31%, and an annual FY2020 reading of $18120.0, changed N/A over the prior year.
  • Treasury Shares was $30667.0 for Q3 2021 at Black Diamond Therapeutics, down from $51007.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $59338.0 in Q1 2021 and bottomed at $18120.0 in Q4 2020.